475i Rifaximin Treatment for 2 Weeks Provides Acute and Sustained Relief Over 12 Weeks of IBS Symptoms in Non-Constipated Irritable Bowel Syndrome: Results From 2 North American Phase 3 Trials (Target 1 and Target 2)

✍ Scribed by Mark Pimentel; Anthony Lembo; William D. Chey; Yehuda Ringel; Salam Zakko; Shadreck M. Mareya; Audrey L. Shaw; Jing Yu; Enoch Bortey; William P. Forbes

• Book ID: 119431143
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 132 KB
• Volume: 138
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/s0016-5085(10)60292-2